Biofrontera Inc. Convertible Notes Payable
Biofrontera Inc. (BFRI) had Convertible Notes Payable of $4.62 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2026-08-13
- 2026-06-30: Convertible Notes Payable $4.62M.
- 2026-03-31: Convertible Notes Payable $4.72M.
- 2025-12-31: Convertible Notes Payable $4.59M.
- 2025-09-30: Convertible Notes Payable $4.46M.
| Period end | Convertible Notes Payable |
|---|---|
| 2026-06-30 | $4.62M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.72M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.59M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $4.46M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.34M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.22M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.10M 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |